- Impact Factor3.6
- Rank31/103 (HEMATOLOGY)
- QuartileQ2
- Citations434
- Rank434
FEATURED ARTICLES
SUPERVISOR

SPONSOR

SPONSOR

PUBLISHER


CURRENT ISSUE
JUST PUBLISHED
RECOMMEDATIONS
CITATION METRICS
JCR
CiteScore
- Impact Factor2.8
- Rank79/142 (Medicine: Hematology)
- Quartile44th
WJCI
- Impact Factor1.196
- Rank76/84 (血液病学)
- QuartileQ4
- Citations128
- Rank128
INDEXING & AWARDS
INDEXING DATABASE
- DOAJ
- PubMed Central
- PubMed
- Scopus
- Emerging Source Citation Index
- Chinese Science and Technology Paper Citation Database
- Embase/EMCare
AWARDS
- High-Starting-Point Journal under Phase I of the Excellence Action Plan for China’s STM Journals
COLLECTIONS
POPULAR ARTICLES
Read
Download
Cited
γδ T cells in hematological malignancies: mechanisms and therapeutic strategies
No. 01 (2025)
CD7 CAR-T therapy: current developments, improvements, and dilemmas
No. 03 (2025)
Enhancing hemophilia A gene therapy by strategic F8 deletions in AAV vectors
No. 01 (2025)
Erythroblastic island: the niche for erythroid terminal differentiation and beyond
No. 02 (2025)
Novel NUP98:TNRC18 fusion transcript in acute myeloid leukemia: a case report and literature review
No. 02 (2025)
INFORMATION
Supervisor:China Association for Science and Technology
Sponsor:Chinese Medical Association; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of Medical Sciences)
Editor-in-chief:Cheng Tao
Contact:Wang Xiaochen
Address:No. 288 Nanjing Road, Heping District, Tianjin, 300020, China
TEL:022-23909358
Email:xcwang@ihcams.ac.cn

















